Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Oncolytics Biotech Inc (TSX: ONC )

3.240 CAD +0.050 (+1.57%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 14, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 117,991
Open 3.160
Bid (Size) 3.220 (1)
Ask (Size) 3.320 (5)
Prev. Close 3.190
Today's Range 3.160 - 3.310
52wk Range 2.040 - 6.060
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Oncolytics Biotech® to Participate in Virtual Fireside Chat at the 2021 RBC Capital Markets Global Healthcare Conference
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that the Company will participate in a virtual fireside chat at the 2021 RBC Capital Markets Global Healthcare Conference, which is... 
From PR Newswire
Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), today announced the voting results from its Annual General Meeting of Shareholders held on Friday, May 7, 2021. A total of 41.41% of the issued and... 
From PR Newswire

Performance

YTD
+8.36%
+8.36%
1 Month
-16.06%
-16.06%
3 Month
-4.99%
-4.99%
6 Month
+21.35%
+21.35%
1 Year
+15.30%
+15.30%

More News

Read More
Oncolytics Biotech® Reports 2021 First Quarter Development Highlights and Financial Results
From PR Newswire
Oncolytics Biotech® Announces Annual General Meeting
From PR Newswire
Oncolytics Biotech® Announces Upcoming Presentation at the American Society of Clinical Oncology Annual Meeting
From PR Newswire
Oncolytics Biotech® and SOLTI Achieve Primary Endpoint in AWARE-1 Study
From PR Newswire
Oncolytics Biotech® Presents Preclinical Data on Pelareorep-based Combination Therapies at the AACR Annual Meeting
From PR Newswire
IIROC Trade Resumption - ONC
From PR Newswire
IIROC Trading Halt - ONC
From PR Newswire
Oncolytics Biotech® to Participate in a Panel Discussion at the Canaccord Genuity Horizons in Oncology Virtual Conference
From PR Newswire
Oncolytics Biotech® to Host Key Opinion Leader Webinar to Discuss AWARE-1 Data, the Immunotherapeutic Effects of Pelareorep in Breast Cancer, and its Synergistic Activity with CAR T Cells in Solid Tum
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.